Current Ratio of BioXcel Therapeutics, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BioXcel Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • BioXcel Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 122%, a 49% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

BioXcel Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 122% -116% -49% 30 Sep 2025
Q2 2025 139% -113% -45% 30 Jun 2025
Q1 2025 186% -108% -37% 31 Mar 2025
Q4 2024 216% -158% -42% 31 Dec 2024
Q3 2024 238% -217% -48% 30 Sep 2024
Q2 2024 252% -383% -60% 30 Jun 2024
Q1 2024 293% -532% -64% 31 Mar 2024
Q4 2023 374% -599% -62% 31 Dec 2023
Q3 2023 454% -770% -63% 30 Sep 2023
Q2 2023 635% -772% -55% 30 Jun 2023
Q1 2023 825% -813% -50% 31 Mar 2023
Q4 2022 972% -754% -44% 31 Dec 2022
Q3 2022 1224% -626% -34% 30 Sep 2022
Q2 2022 1407% -343% -20% 30 Jun 2022
Q1 2022 1638% +371% +29% 31 Mar 2022
Q4 2021 1726% +657% +62% 31 Dec 2021
Q3 2021 1850% +1057% +133% 30 Sep 2021
Q2 2021 1750% +1246% +247% 30 Jun 2021
Q1 2021 1267% +752% +146% 31 Mar 2021
Q4 2020 1069% +608% +132% 31 Dec 2020
Q3 2020 793% +236% +42% 30 Sep 2020
Q2 2020 504% -241% -32% 30 Jun 2020
Q1 2020 516% -692% -57% 31 Mar 2020
Q4 2019 461% -1150% -71% 31 Dec 2019
Q3 2019 557% -1005% -64% 30 Sep 2019
Q2 2019 745% 30 Jun 2019
Q1 2019 1208% 31 Mar 2019
Q4 2018 1611% 31 Dec 2018
Q3 2018 1562% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.